Prevalence of Neovascular Glaucoma in King Chulalongkorn Memorial Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210915001

Enrollment

Registered

2021-09-15

Start date

2021-08-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with neovascular glaucoma in King Chulalongkorn Memorial Hospital during 2010 to 2022 Neovascular glaucoma

Interventions

patients diagnosed as NVG who received Anti-VEGF in all routes,patients diagnosed as NVG who were not received Anti-VEGF in all routes

Treatment,Treatment

Group1 Anti-VEGF,Group2 No Anti-VEGF

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in King Chulalongkorn Memorial Hospital diagnosed with neovascular glaucoma during 2021-2022

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Intraocular pressure 5 year chart review, mmHg,Visual acuity 5 year chart review, LogMar	—

Secondary

Measure	Time frame
Recurrence of neovascular glaucoma 5 year chart review, event	—

Countries

Thailand

Contacts

Public ContactJanrapee Sukkee

Glaucoma Research Unit, Faculty of Medicine, Chulalongkorn university

chulaglaucoma@gmail.com026494000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026